Delivery Order SPE2DB20D3103-SPE2DB25FP1E5

Award Date 6/10/25
Potential Completion Date 7/2/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,917.64 and a performance period ending on July 2, 2025. The contract is not set-aside and was awarded on June 10, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA). The $1,188.34 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 14, 2024, with a completion date of September 5, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $7,376.46. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a period of performance through June 9, 2025. This appears to be a non-set-aside contract, meaning it was open to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $4,917.64 with a firm fixed price and an ultimate completion date of June 16, 2025. The contract is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The fixed-price contract, valued at $2,376.70, will run through November 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a prescription medication. The contract has a firm fixed price of $3,688.23 and a completion date of June 11, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA), a defense agency. The ceiling value of the contract is $3,565.02, and it is a firm fixed price delivery order contract awarded to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract has no set-aside designation and will be performed in Conshohocken, PA. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products. This is a Firm Fixed Price delivery order contract that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is a delivery order for the product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. It is a firm fixed-price contract with a completion date of June 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $3,565.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical product, with a period of performance ending on December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP1E5
    Delivery Order

This federal contract award is for the delivery of pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA), a defense agency. The $7,376.46 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 10, 2025, with a performance period extending through July 2, 2025.

The contract is not designated as a set-aside and is therefore open to full and open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/9/25, 12:58 PM